Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine added to standard quadruple therapy for Helicobacter pylori eradication
IRCT201605201155N24Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of acetylcysteine in Helicobacter pylori infection (2 arms), sponsored by Guilan University of Medical Sciences. Primary endpoint: Helicobacter pylori eradication rate. Started Aug 2016; status: completed.
02
Drugs
acetylcysteine
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on IRCT201605201155N24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201605201155N24.